Skip to main content
Top
Published in: Current Hepatology Reports 3/2018

01-09-2018 | Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?

Authors: Elliot B. Tapper, Roberto Martinez-Macias, Andres Duarte-Rojo

Published in: Current Hepatology Reports | Issue 3/2018

Login to get access

Abstract

Purpose of Review

In spite of the many health benefits attributed to exercise, reports summarizing the literature in patients with cirrhosis are scarce. We aimed to provide a comprehensive review focusing on potential safety considerations in cirrhosis.

Recent Findings

Diminished exercise capacity in patients with cirrhosis worsens their prognosis before and after liver transplantation. Exercise poses unique challenges in this population, raising questions of safety—worsening portal hypertension and malnutrition—and efficacy. In this review, we show that the balance of evidence supports supervised exercise programs with demonstrable benefits with respect to portal pressure, functional capacity, and muscle mass indexes. There are also benefits regarding their emotional function and perceived general health. Key to interpreting the benefits and risk profile of exercise is the impact of non-selective beta-blockage.

Summary

Patients with cirrhosis, with or without portal hypertension, should receive an exercise prescription as part of their standard of care. However, some standard safety recommendations should be universally followed.
Literature
1.
go back to reference Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–90.CrossRef Tapper EB, Finkelstein D, Mittleman MA, Piatkowski G, Lai M. Standard assessments of frailty are validated predictors of mortality in hospitalized patients with cirrhosis. Hepatology. 2015;62:584–90.CrossRef
2.
go back to reference Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–53.CrossRef Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106:1646–53.CrossRef
3.
go back to reference Patel AA, Walling AM, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.CrossRef Patel AA, Walling AM, May FP, Saab S, Wenger N. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612–1619.e4.CrossRef
4.
go back to reference Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology 2017. https://doi.org/10.1002/hep.29473. [Epub ahead of print]. Parikh ND, Marrero WJ, Wang J, et al. Projected increase in obesity and non-alcoholic steatohepatitis-related liver transplantation waitlist additions in the United States. Hepatology 2017. https://​doi.​org/​10.​1002/​hep.​29473. [Epub ahead of print].
5.
go back to reference Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30. e1.CrossRef Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin Gastroenterol Hepatol. 2011;9:524–30. e1.CrossRef
6.
go back to reference Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.CrossRef Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.CrossRef
7.
go back to reference Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S. Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14:88–95.CrossRef Neviere R, Edme JL, Montaigne D, Boleslawski E, Pruvot FR, Dharancy S. Prognostic implications of preoperative aerobic capacity and exercise oscillatory ventilation after liver transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2014;14:88–95.CrossRef
8.
go back to reference Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, Mcphail MJ, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54–62.CrossRef Bernal W, Martin-Mateos R, Lipcsey M, Tallis C, Woodsford K, Mcphail MJ, et al. Aerobic capacity during cardiopulmonary exercise testing and survival with and without liver transplantation for patients with chronic liver disease. Liver Transpl. 2014;20:54–62.CrossRef
9.
go back to reference Prentis JM, Manas DM, Trenell MI, Hudson M, Jones DJ, Snowden CP. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–9.CrossRef Prentis JM, Manas DM, Trenell MI, Hudson M, Jones DJ, Snowden CP. Submaximal cardiopulmonary exercise testing predicts 90-day survival after liver transplantation. Liver Transpl. 2012;18:152–9.CrossRef
10.
go back to reference • Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6. Initial description of increased portal pressure associated with exercise. CrossRef • Garcia-Pagan JC, Santos C, Barbera JA, et al. Physical exercise increases portal pressure in patients with cirrhosis and portal hypertension. Gastroenterology. 1996;111:1300–6. Initial description of increased portal pressure associated with exercise. CrossRef
11.
go back to reference Bandi JC, García-Pagán JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology (Baltimore, Md). 1998;28:677–82.CrossRef Bandi JC, García-Pagán JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology (Baltimore, Md). 1998;28:677–82.CrossRef
12.
go back to reference •• Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180. Randomized controlled trial showing a decrease in portal pressure in relation to an exercise program. CrossRef •• Macias-Rodriguez RU, Ilarraza-Lomeli H, Ruiz-Margain A, et al. Changes in hepatic venous pressure gradient induced by physical exercise in cirrhosis: results of a pilot randomized open clinical trial. Clin Transl Gastroenterol. 2016;7:e180. Randomized controlled trial showing a decrease in portal pressure in relation to an exercise program. CrossRef
13.
go back to reference •• Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305. The largest non-controlled clinical trial showing a decrease in portal pressure as a result of weight loss and exercise. CrossRef •• Berzigotti A, Albillos A, Villanueva C, et al. Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: the SportDiet study. Hepatology. 2017;65:1293–305. The largest non-controlled clinical trial showing a decrease in portal pressure as a result of weight loss and exercise. CrossRef
14.
go back to reference Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017;66:142–52.CrossRef Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: a systematic review. J Hepatol. 2017;66:142–52.CrossRef
15.
go back to reference Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 2016;14:1398–411.CrossRef Orci LA, Gariani K, Oldani G, Delaune V, Morel P, Toso C. Exercise-based interventions for nonalcoholic fatty liver disease: a meta-analysis and meta-regression. Clin Gastroenterol Hepatol. 2016;14:1398–411.CrossRef
16.
go back to reference •• Roman E, Torrades MT, Nadal MJ, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–75. A randomized controlled trial using a supervised intervention along with amino acid supplementation expected to positively impact on sarcopenia. CrossRef •• Roman E, Torrades MT, Nadal MJ, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966–75. A randomized controlled trial using a supervised intervention along with amino acid supplementation expected to positively impact on sarcopenia. CrossRef
17.
go back to reference Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS One. 2016;11:e0151652.CrossRef Roman E, Garcia-Galceran C, Torrades T, et al. Effects of an exercise programme on functional capacity, body composition and risk of falls in patients with cirrhosis: a randomized clinical trial. PLoS One. 2016;11:e0151652.CrossRef
18.
go back to reference Debette-Gratien M, Tabouret T, Antonini M-T, Dalmay F, Carrier P, Legros R, et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015;99:145–50.CrossRef Debette-Gratien M, Tabouret T, Antonini M-T, Dalmay F, Carrier P, Legros R, et al. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015;99:145–50.CrossRef
19.
go back to reference Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–6 e2.CrossRef Zenith L, Meena N, Ramadi A, et al. Eight weeks of exercise training increases aerobic capacity and muscle mass and reduces fatigue in patients with cirrhosis. Clin Gastroenterol Hepatol. 2014;12:1920–6 e2.CrossRef
20.
go back to reference •• Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99. A randomized controlled trial with positive results on aerobic fitness, using a novel approach including home-based exercise and physical trainers. CrossRef •• Kruger C, McNeely ML, Bailey RJ, et al. Home exercise training improves exercise capacity in cirrhosis patients: role of exercise adherence. Sci Rep. 2018;8:99. A randomized controlled trial with positive results on aerobic fitness, using a novel approach including home-based exercise and physical trainers. CrossRef
21.
go back to reference Konishi I, Hiasa Y, Tokumoto Y, Abe M, Furukawa S, Toshimitsu K, et al. Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res. 2011;41:928–35.CrossRef Konishi I, Hiasa Y, Tokumoto Y, Abe M, Furukawa S, Toshimitsu K, et al. Aerobic exercise improves insulin resistance and decreases body fat and serum levels of leptin in patients with hepatitis C virus. Hepatol Res. 2011;41:928–35.CrossRef
22.
go back to reference Pattullo V, Duarte-Rojo A, Soliman W, Vargas-Vorackova F, Sockalingam S, Fantus IG, et al. A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver Int. 2013;33:410–9.CrossRef Pattullo V, Duarte-Rojo A, Soliman W, Vargas-Vorackova F, Sockalingam S, Fantus IG, et al. A 24-week dietary and physical activity lifestyle intervention reduces hepatic insulin resistance in the obese with chronic hepatitis C. Liver Int. 2013;33:410–9.CrossRef
23.
go back to reference Nishida Y, Ide Y, Okada M, Otsuka T, Eguchi Y, Ozaki I, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193–200.CrossRef Nishida Y, Ide Y, Okada M, Otsuka T, Eguchi Y, Ozaki I, et al. Effects of home-based exercise and branched-chain amino acid supplementation on aerobic capacity and glycemic control in patients with cirrhosis. Hepatol Res. 2017;47:E193–200.CrossRef
24.
go back to reference Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRef Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, et al. Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis. Eur J Gastroenterol Hepatol. 2017;29:1416–23.CrossRef
25.
go back to reference Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology (Baltimore, Md). 2016;63:1184–9.CrossRef Tapper EB, Lai M. Weight loss results in significant improvements in quality of life for patients with nonalcoholic fatty liver disease: a prospective cohort study. Hepatology (Baltimore, Md). 2016;63:1184–9.CrossRef
26.
go back to reference • Ney M, Haykowsky M, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre-and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther. 2016;44:796–806. A systematic review evaluating the importance of cardiopulmonary endurance in prognostication of liver transplant candidates. CrossRef • Ney M, Haykowsky M, Vandermeer B, Shah A, Ow M, Tandon P. Systematic review: pre-and post-operative prognostic value of cardiopulmonary exercise testing in liver transplant candidates. Aliment Pharmacol Ther. 2016;44:796–806. A systematic review evaluating the importance of cardiopulmonary endurance in prognostication of liver transplant candidates. CrossRef
27.
go back to reference Wallen MP, Hall A, Dias KA, Ramos JS, Keating SE, Woodward AJ, et al. Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease. Aliment Pharmacol Ther. 2017;46:741–7.CrossRef Wallen MP, Hall A, Dias KA, Ramos JS, Keating SE, Woodward AJ, et al. Impact of beta-blockers on cardiopulmonary exercise testing in patients with advanced liver disease. Aliment Pharmacol Ther. 2017;46:741–7.CrossRef
28.
go back to reference Bandi JC, Garcia-Pagan JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998;28:677–82.CrossRef Bandi JC, Garcia-Pagan JC, Escorsell A, et al. Effects of propranolol on the hepatic hemodynamic response to physical exercise in patients with cirrhosis. Hepatology. 1998;28:677–82.CrossRef
29.
go back to reference Salo J, Guevara M, Fernandez-Esparrach G, Bataller R, Gines A, Jimenez W, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRef Salo J, Guevara M, Fernandez-Esparrach G, Bataller R, Gines A, Jimenez W, et al. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems. Hepatology. 1997;25:1338–42.CrossRef
30.
go back to reference Eriksson LS, Broberg S, Bjorkman O, Wahren J. Ammonia metabolism during exercise in man. Clin Physiol. 1985;5:325–36.CrossRef Eriksson LS, Broberg S, Bjorkman O, Wahren J. Ammonia metabolism during exercise in man. Clin Physiol. 1985;5:325–36.CrossRef
31.
go back to reference Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol. 2005;563:285–90.CrossRef Nybo L, Dalsgaard MK, Steensberg A, Moller K, Secher NH. Cerebral ammonia uptake and accumulation during prolonged exercise in humans. J Physiol. 2005;563:285–90.CrossRef
32.
go back to reference Yuan Y, Chan KM. A longitudinal study on the ammonia threshold in junior cyclists. Br J Sports Med. 2004;38:115–9.CrossRef Yuan Y, Chan KM. A longitudinal study on the ammonia threshold in junior cyclists. Br J Sports Med. 2004;38:115–9.CrossRef
33.
go back to reference Dietrich R, Bachmann C, Lauterburg BH. Exercise-induced hyperammonemia in patients with compensated chronic liver disease. Scand J Gastroenterol. 1990;25:329–34.CrossRef Dietrich R, Bachmann C, Lauterburg BH. Exercise-induced hyperammonemia in patients with compensated chronic liver disease. Scand J Gastroenterol. 1990;25:329–34.CrossRef
34.
go back to reference Soriano G, Roman E, Cordoba J, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55:1922–30.CrossRef Soriano G, Roman E, Cordoba J, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55:1922–30.CrossRef
35.
go back to reference Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med. 2004;34:293–306.CrossRef Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med. 2004;34:293–306.CrossRef
36.
go back to reference Chatard JC, Mujika I, Goiriena JJ, Carre F. Screening young athletes for prevention of sudden cardiac death: practical recommendations for sports physicians. Scand J Med Sci Sports. 2016;26:362–74.CrossRef Chatard JC, Mujika I, Goiriena JJ, Carre F. Screening young athletes for prevention of sudden cardiac death: practical recommendations for sports physicians. Scand J Med Sci Sports. 2016;26:362–74.CrossRef
37.
go back to reference Kazankov K, Munk K, Ovrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Investig. 2017;47:565–73.CrossRef Kazankov K, Munk K, Ovrehus KA, et al. High burden of coronary atherosclerosis in patients with cirrhosis. Eur J Clin Investig. 2017;47:565–73.CrossRef
38.
go back to reference Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605–13.CrossRef Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, et al. Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology. 2012;56:605–13.CrossRef
39.
go back to reference Hupin D, Edouard P, Oriol M, Laukkanen J, Abraham P, Doutreleau S, et al. Exercise electrocardiogram in middle-aged and older leisure time sportsmen: 100 exercise tests would be enough to identify one silent myocardial ischemia at risk for cardiac event. Int J Cardiol. 2018;257:16–23.CrossRef Hupin D, Edouard P, Oriol M, Laukkanen J, Abraham P, Doutreleau S, et al. Exercise electrocardiogram in middle-aged and older leisure time sportsmen: 100 exercise tests would be enough to identify one silent myocardial ischemia at risk for cardiac event. Int J Cardiol. 2018;257:16–23.CrossRef
40.
go back to reference Riebe D, Franklin BA, Thompson PD, et al. Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47:2473–9.CrossRef Riebe D, Franklin BA, Thompson PD, et al. Updating ACSM’s recommendations for exercise preparticipation health screening. Med Sci Sports Exerc. 2015;47:2473–9.CrossRef
41.
go back to reference Ezaz G, Murphy SL, Mellinger J, Tapper EB. Increased morbidity and mortality associated with falls among patients with cirrhosis. Am J Med. 2018;131:645–650.e2.CrossRef Ezaz G, Murphy SL, Mellinger J, Tapper EB. Increased morbidity and mortality associated with falls among patients with cirrhosis. Am J Med. 2018;131:645–650.e2.CrossRef
42.
go back to reference United States. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! Washington, DC: U.S. Dept. of Health and Human Services; 2008. United States. Department of Health and Human Services. 2008 physical activity guidelines for Americans : be active, healthy, and happy! Washington, DC: U.S. Dept. of Health and Human Services; 2008.
43.
go back to reference Lai CC, Tu YK, Wang TG, Huang YT, Chien KL. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47:367–73.CrossRef Lai CC, Tu YK, Wang TG, Huang YT, Chien KL. Effects of resistance training, endurance training and whole-body vibration on lean body mass, muscle strength and physical performance in older people: a systematic review and network meta-analysis. Age Ageing. 2018;47:367–73.CrossRef
44.
go back to reference Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplast. 2005;20:460–6.CrossRef Cohen SM, Te HS, Levitsky J. Operative risk of total hip and knee arthroplasty in cirrhotic patients. J Arthroplast. 2005;20:460–6.CrossRef
45.
go back to reference Bhasin S, Apovian CM, Travison TG, Pencina K, Moore LL, Huang G, et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern Med. 2018;178:530–41.CrossRef Bhasin S, Apovian CM, Travison TG, Pencina K, Moore LL, Huang G, et al. Effect of protein intake on lean body mass in functionally limited older men: a randomized clinical trial. JAMA Intern Med. 2018;178:530–41.CrossRef
46.
go back to reference • Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39. Comprehensive review on the role of disorders of physical function disorders/sarcopenia and exercise in liver transplant candidates. CrossRef • Duarte-Rojo A, Ruiz-Margain A, Montano-Loza AJ, Macias-Rodriguez RU, Ferrando A, Kim WR. Exercise and physical activity for patients with end-stage liver disease: improving functional status and sarcopenia while on the transplant waiting list. Liver Transpl. 2018;24:122–39. Comprehensive review on the role of disorders of physical function disorders/sarcopenia and exercise in liver transplant candidates. CrossRef
Metadata
Title
Is Exercise Beneficial and Safe in Patients with Cirrhosis and Portal Hypertension?
Authors
Elliot B. Tapper
Roberto Martinez-Macias
Andres Duarte-Rojo
Publication date
01-09-2018
Publisher
Springer US
Published in
Current Hepatology Reports / Issue 3/2018
Electronic ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-018-0404-z

Other articles of this Issue 3/2018

Current Hepatology Reports 3/2018 Go to the issue

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

Innovative Care Models in Liver Disease: the Role of Multidisciplinary Teams

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease

Portal Hypertension (J Gonzalez-Abraldes and E Tsochatzis, Section Editors)

The Portosystemic Shunt Syndrome and Role of Shunt Embolization in the Management of Hepatic Encephalopathy

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Uncommon Presentations of Idiosyncratic Drug-Induced Liver Injury

Drug-Induced Liver Injury (NP Chalasani and MS Ghabril, Section Editors)

Drug-Induced Liver Injury: Understanding the Different Immune-Mediated Phenotypes and Clinical Management